Department of Cardiology, Bern University Hospital, Bern, Switzerland.
Am Heart J. 2010 Jun;159(6):1147-53. doi: 10.1016/j.ahj.2010.03.012.
Although rare, iatrogenic left main coronary artery (LM) dissection is a feared complication of coronary catheterization. Its incidence, optimal therapeutic management, and prognosis remain largely unknown. The aim of the present study was to estimate the incidence, characterize the population at risk, depict the initial management, and evaluate the long-term prognosis of iatrogenic LM dissection.
Thirty-eight patients who fulfilled the National Heart, Lung, and Blood Institute diagnostic criteria for iatrogenic LM dissection were retrieved from our database and followed up by telephone or physician visit. The primary end point was freedom from major adverse cardiac events (MACE) at 5 years.
The overall incidence of iatrogenic LM dissection during the study period was 0.07% (38/51,452 patients) and almost twice as common with percutaneous coronary intervention than coronary angiography. From 38 patients, 1 (3%) patient died before any therapeutic attempt was performed, 6 (16%) patients were treated conservatively, and 31 (82%) patients underwent stent implantation and/or coronary artery bypass grafting (CABG). In-hospital outcome was favorable irrespective of the therapeutic strategy. During the 5-year follow-up, among 31 patients who underwent revascularization treatment by stenting or CABG, one patient died in each group from a cardiac cause, and MACE were observed in 12 patients (39%). Kaplan-Meier cumulative survival estimates showed no significant difference between different revascularization treatment strategies.
Iatrogenic LM dissection is a rare complication of cardiac catheterization procedures with favorable early and long-term outcome when recognized timely and managed properly.
尽管罕见,但医源性左主干冠状动脉(LM)夹层是冠状动脉介入治疗的一种可怕并发症。其发生率、最佳治疗管理方法和预后仍知之甚少。本研究旨在评估医源性 LM 夹层的发生率、特征人群、初始处理方法,并评估其长期预后。
从我们的数据库中检索到符合美国国立心肺血液研究所医源性 LM 夹层诊断标准的 38 例患者,并通过电话或医生访视进行随访。主要终点是 5 年内无主要不良心脏事件(MACE)。
研究期间医源性 LM 夹层的总发生率为 0.07%(38/51452 例患者),经皮冠状动脉介入术的发生率几乎是冠状动脉造影的两倍。在 38 例患者中,1 例(3%)患者在进行任何治疗尝试前死亡,6 例(16%)患者接受保守治疗,31 例(82%)患者接受支架植入术和/或冠状动脉旁路移植术(CABG)。无论采用何种治疗策略,住院期间结局均良好。在 5 年随访期间,在接受支架置入或 CABG 血运重建治疗的 31 例患者中,每组各有 1 例患者因心脏原因死亡,12 例(39%)患者发生 MACE。Kaplan-Meier 累积生存估计表明,不同血运重建治疗策略之间无显著差异。
医源性 LM 夹层是一种罕见的心脏导管术并发症,如能及时发现和正确处理,其早期和长期预后良好。